This Regulation is short and tightly scoped. Its core legal concepts are the particularisations required by the parent Act. The instrument sets definitions or prescribed particulars rather than creating new free‑standing prohibitions. The main operative concepts are:

• Prescribed contaminant (clause 4). The Regulation supplies the specific organisms/substances that are to be treated as "prescribed contaminants" for the Act’s definitions. The list is discrete and biological in nature; it identifies viral agents (hepatitis B and C, HIV, HTLV‑I) and treponema pallidum (syphilis) markers (antigens and antibodies where applicable).
• Classes of designated specialists (clause 5). For the Act’s provision that requires a "designated specialist", the Regulation prescribes specialties that qualify. It cross‑references the Health Practitioner Regulation National Law (NSW) for the meanings of "health profession" and "specialist registration". The concept therefore depends on registration under the National Law and narrows who may be treated as a specialist for the Act’s processes.
• Certificate, witness and retention rules (clause 6 and Schedule 1). The Regulation prescribes the form of the blood donor certificate (sch 1), specifies who may be a witness when blood is removed at the place of employment (medical practitioners, nurses, donor services nursing assistants at the Australian Red Cross Society, and employer‑nominated persons approved in writing by the Secretary), and requires retention of signed certificates for not less than 10 years by either the person who removed the blood or the employer/agent (clause 6(2)-(3); sch 1). The concept of "certificate" is therefore operationalised as a physical form with a set of questions and a statutory record‑keeping duty.
• Presumption as to carrying on a blood supply business (clause 7). The Regulation fixes a quantitative threshold: 1 litre as the prescribed quantity of blood, and the equivalent quantity of blood products extractable from that litre, for the Act’s section 21A(b) presumption.
• Verbal consent with recording and emergency retention (clause 8). The Regulation allows senior available next of kin to give consent orally for removal of tissue after death if the consent is recorded (audio or audiovisual) and the next of kin has consented to the recording. It separately allows tissue removed during urgent treatment to be retained for up to 72 hours where the removal was necessary to save life or prevent serious damage to health (clause 8(1)-(2)).
• Repeal and savings (clause 9). The Regulation repeals the 2015 Regulation but preserves continuity for acts and matters that previously had effect.

Each of these concepts is framed as a statutory prescription for the Act’s definitions and operative sections. The Regulation therefore mainly functions to convert higher‑level statutory language into administrable, enforceable particulars: named organisms, named specialties, a prescribed certificate, a simple quantitative threshold and a limited set of procedural rules for consent and retention.

The Regulation affects a narrow but intersecting set of actors. The text identifies who is required to act, who may act in particular roles, and who bears record‑keeping obligations.

• Blood donors and blood collectors. The Schedule prescribes the blood donor certificate form and includes a signed declaration for donors (Schedule 1). Donors are required under that form to answer specific health and behaviour questions and to sign the declaration in the presence of an interviewer (sch 1). The form also contains a statutory warning that there are penalties, including fines and imprisonment, for providing false or misleading information; the Regulation thereby signals legal exposure for donors who falsify answers (sch 1).
• Persons who remove blood. Clause 6(3) requires the person who removed the blood, or if the removal was in the course of employment the employer or principal, to retain the certificate for at least 10 years. Failure to retain attracts a maximum penalty of 2 penalty units (clause 6(3)). The obligation therefore falls first on the individual practitioner and secondarily on their employing body.
• Employers and employing bodies. Where blood is removed by an employee or agent, the employing person or body is the alternative certificate custodian (clause 6(3)). Employers also have a role in nominating and obtaining Secretary approval for persons authorised to witness signatures in employment settings (clause 6(2)(d)), so they must develop compliance processes for nomination and maintain any approvals.
• Witnesses to certificates. The Regulation prescribes categories of persons who may act as witnesses when the blood is removed at the place of employment: medical practitioners, nurses, Australian Red Cross donor services nursing assistants, and employer‑nominated persons approved by the Secretary (clause 6(2)). Witnesses must be employed where the blood is removed.
• Health practitioners as designated specialists. Clause 5 prescribes the specialties whose holders may be treated as designated specialists under the Act. The qualification depends on holding specialist registration in one of the listed specialties under the Health Practitioner Regulation National Law (NSW). This affects registered specialists in anaesthesia, emergency medicine, intensive care medicine, obstetrics and gynaecology, physician specialties and surgery.
• Next of kin and families. Clause 8 permits the "senior available next of kin" to give verbal consent to removal of tissue after death where an audio or audiovisual recording of the consent is made and the next of kin has consented to the recording. This affects how families participate in consent processes for post‑mortem tissue removal and requires them to agree to recording.
• The Secretary (an agency official). Clause 6(2)(d) gives the Secretary discretion to approve nominated persons in writing as appropriate witnesses. That creates a gatekeeping and administrative role for the Secretary in approving non‑medical witnesses in employment contexts.
• Operators of blood supply businesses. Clause 7’s presumption that 1 litre of blood, or the blood products extractable from 1 litre, is the prescribed quantity for treating someone as carrying on a blood supply business affects small suppliers and operators who handle borderline quantities. Those operators will need to assess whether their volumes meet or exceed the statutory presumption.

The cumulative effect is to distribute compliance tasks and legal exposure across donors, clinical practitioners, employing bodies, health‑registration institutions (indirectly via the National Law cross‑reference), and a Secretary with approval authority. The Regulation’s record‑keeping and witness prescription obligations create concrete administrative responsibilities for employers and practitioners; the donor certificate places disclosure obligations on donors backed by a written warning about penalties.

The Regulation creates or clarifies discrete duties and limited rights. The instruments of duty are mostly prescriptive: fill out the prescribed form, retain records for fixed periods, obtain recorded consent in certain cases, and nominate/approve witnesses. Rights are primarily procedural (e.g. the right for a senior available next of kin to give verbal consent provided conditions are met). Below are the main duties and the procedural or protective rights the Regulation recognises.

Duties

• Use the prescribed blood donor certificate form for the purposes of section 20D(1) of the Act (clause 6(1); Schedule 1). The Certificate’s questions must be presented to donors and the donor must sign "in the presence of the interviewer" (sch 1).
• Ensure that, where blood is removed at the place of employment, the witness to any certificate is one of the prescribed categories: medical practitioner, nurse, a donor services nursing assistant employed by the Australian Red Cross Society, or an employer‑nominated person approved in writing by the Secretary (clause 6(2)(a)-(d)).
• Retain each certificate signed under section 20D of the Act for not less than 10 years from the date of signing. The primary retention duty is on the person who removed the blood; where removal occurs in that person’s capacity as an employee or agent, the employer or body is the custodian (clause 6(3)). Failure to retain attracts a maximum penalty of 2 penalty units (clause 6(3)).
• For entities handling blood or blood products, apply the statutory presumption that dealing in at least 1 litre of blood, or the blood products derivable from it, satisfies the Act’s carrying on a blood supply business threshold (clause 7).
• For removals of tissue after death where consent from the senior available next of kin is given verbally, ensure an audio or audiovisual recording of the consent and ensure the next of kin consents to that recording (clause 8(1)). This is a precondition of the verbal consent mechanism.
• Where tissue is removed during urgent treatment to save life or prevent serious damage to health, the tissue may be retained for up to 72 hours (clause 8(2)). That creates a duty to limit retention to that period unless another lawful basis exists.

Rights and procedural protections

• The Regulation recognises the procedural right of a senior available next of kin to give verbal consent in a recorded form, subject to the conditions in clause 8(1). The right is defined narrowly: the consent may be given verbally only if (a) an audio or audiovisual recording is made and (b) the next of kin has consented to the making of that recording.
• Individuals completing the blood donor certificate have the right to receive and sign the prescribed form; the form requires them to declare their answers are honest and informs them that false or misleading statements attract penalties (sch 1). That operates as both a notification right and a deterrent.
• Employers and employing bodies have the right to nominate persons to witness signatures in employment settings, subject to written approval by the Secretary (clause 6(2)(d)). That right is conditional on Secretary approval.

Discretion and administrative decision points

• The Secretary holds discretion to approve, in writing, employer‑nominated persons as appropriate witnesses (clause 6(2)(d)). That creates an explicit administrative decision point and a pathway for workplaces to expand the witness pool beyond health practitioners and specified Australian Red Cross roles.
• The Regulation’s cross‑references (clause 5 reference to the Health Practitioner Regulation National Law) convert registration status under that National Law into the operative test for specialist status. Holders of specialist registration therefore occupy a defined legal status for the Act’s purposes.

Limits on duties in the Regulation

• The Regulation sets a short, explicit penal exposure only for the certificate retention duty (maximum penalty 2 penalty units) (clause 6(3)). The Schedule’s reference to penalties for false information is communicative but not quantified in the Regulation text. Other penalties or enforcement mechanisms are contained in the Act and are not restated here.

In sum, the Regulation imposes record‑keeping and form‑use duties, prescribes who may act as specified categories of witnesses and specialists, gives a statutory quantity presumption for blood businesses, and creates a procedural consent right limited to recorded verbal consent by senior available next of kin. The Secretary’s approval role creates a single point of administrative discretion for employer‑nominated witnesses.

The Regulation itself contains a very narrow set of penal provisions and embeds other potential penal consequences through the Schedule’s declaration wording. The explicit and implicit enforcement elements in the Regulation are as follows.

Express penalty in the Regulation

• Clause 6(3) requires retention of certificates for at least 10 years and makes a contravention a punishable offence. The specific text: "A certificate signed for the purposes of section 20D of the Act must be retained, for a period of not less than 10 years from the date on which it was signed, by (a) the person who removed the blood, or (b) if the person who removed the blood did so in the person’s capacity as an employee or agent of some other person or body,that other person or body. Maximum penalty,2 penalty units." That is the Regulation’s sole quantified penalty.
• The Regulation does not set out enforcement mechanisms (no administrative fines, compliance notices or the like are introduced here). It therefore relies on the Act’s enforcement architecture for other contraventions that the Act governs but does not replicate.

Penalties signalled by Schedule 1

• Schedule 1 contains a donor declaration that states: "I understand that there are penalties, including fines and imprisonment, for providing false or misleading information." The Schedule does not quantify these penalties nor identify the provision under which they are imposed; it functions as a statutory notification on the form. The text thereby signals criminal or other penal exposure for false or misleading statements by donors without specifying the legal basis in the Regulation.

Enforcement actors

• The Regulation assigns an approval function to the Secretary for employer‑nominated witnesses (clause 6(2)(d)), which implicitly places administrative oversight and gatekeeping in the Secretary’s hands. The Regulation does not set out the Secretary’s enforcement tools or procedures for revoking approvals.
• The Regulation’s reference to the Act (clause 3(1)) and prescribed matters throughout implies that enforcement of many substantive duties will occur under the Act’s provisions. The Regulation itself restricts explicit penalties to the certificate‑retention requirement.

Practical enforcement implications and scope

• The single quantified penalty is small in scale: 2 penalty units. The Regulation therefore treats the failure to retain certificates as a regulatory‑compliance offence with relatively modest statutory maximum exposure compared with offences that might be contained in the Act (not reproduced here). That creates a compliance incentive for practitioners and employers to maintain records for the 10‑year period, but the Regulation does not establish graduated penalties, enforcement priorities or inspection regimes.
• The Schedule’s penal warning to donors may be relied upon when enforcing donor disclosure obligations under the Act, but this Regulation does not itself provide the enforcement steps or prosecutorial thresholds.

In short, the Regulation provides an express, quantified penalty only for non‑retention of certificates (clause 6(3)), and a non‑quantified warning of penalties for false or misleading donor responses on the prescribed form (Schedule 1). Broader enforcement of the Act’s regimes remains a matter of the Act and administrative practice; the Regulation provides the operational details that enforcement authorities will use when applying the Act but does not itself create a comprehensive enforcement architecture.

The Regulation deliberately operates as a subordinate instrument to the Human Tissue Act 1983 and makes cross‑references to other NSW instruments. Its operative interaction points are explicit in the text; the Regulation does not attempt to rewrite or displace the parent Act. The main interaction features are:

• Direct subordination to the Human Tissue Act 1983 (clause 3(1)). The Regulation defines "the Act" as the Human Tissue Act 1983 and supplies particulars used by the Act. The Regulation therefore fills in definitional and procedural gaps left to subordinate legislation by the Act. Any substantive enforcement or criminal rules that are not specified here remain governed by the Act.
• Cross‑reference to the Interpretation Act 1987 (clause 3(1) note). The Regulation notes that the Interpretation Act 1987 contains definitions and provisions that affect interpretation and application of the Regulation, signalling that standard statutory interpretation and time, service or commencement rules in the Interpretation Act apply.
• Interaction with the Health Practitioner Regulation National Law (NSW) (clause 5(2)). Clause 5 prescribes specialist registration in specified specialties as the test for a "designated specialist" under the Act and states that "health profession" and "specialist registration" have the same meanings as in the Health Practitioner Regulation National Law (NSW). That makes the National Law the legal source for who counts as a specialist, linking state subordinate regulations to national registration regimes.
• Reference to the Subordinate Legislation Act 1989 (clause 2 note). The commencement note explains the Regulation repeals and replaces the 2015 Regulation which would otherwise have been repealed by section 10(2) of the Subordinate Legislation Act 1989 on a future date. This records a procedural interaction with the statute governing subordinate instruments.
• Administrative interaction via Secretary approvals (clause 6(2)(d)). The Secretary’s authority to approve employer‑nominated witnesses in writing creates an administrative link with whichever department or agency provides the Secretary. Any approvals, variations or revocations will operate within the administrative law framework applicable to that Secretary and the Department, including procedural fairness principles and statutory powers, though those frameworks are not stated in the Regulation.
• Signals to health‑sector criminal and regulatory provisions without restating them. The Schedule’s declaration about penalties for false or misleading information indicates that the donor’s declarations may be enforced under other statutory provisions (likely within the Act or other NSW criminal statutes), but the Regulation does not specify those offences or penalties. Practitioners and employers must therefore map the Regulation’s procedural rules onto the Act’s substantive offences and any relevant criminal law or administrative sanctions.

The Regulation therefore functions as a bridge between the Act and operational practices, and between state subordinate regulation and national registration law. It fixes certain testable matters (e.g. what contaminants are prescribed, what counts as a specialist, the witness categories), but it relies on the parent Act, the Interpretation Act, the National Law and administrative practice for many substantive consequences and for enforcement mechanisms beyond the one small penalty it prescribes. Entities implementing the Regulation must therefore coordinate compliance with the parent Act and be aware that specialist recognition depends on national registration criteria.

The Regulation text includes a concise amendment and repeal history and records two Schedule 1 amendments. The explicit history in the instrument is as follows:

• Repeal of the Human Tissue Regulation 2015 (clause 9(1)). Clause 9(1) expressly repeals the Human Tissue Regulation 2015 and clause 2 notes that the Regulation commences on publication, replacing the earlier instrument which would otherwise have been repealed on 1 September 2020 by section 10(2) of the Subordinate Legislation Act 1989. The Regulation thus functions as a replacement subordinate instrument with preservation of prior effect where necessary (clause 9(2)).
• Savings provision (clause 9(2)). Acts, matters or things that had effect under the 2015 Regulation immediately before repeal continue to have effect under this Regulation. That is a continuity mechanism to avoid legal gaps resulting from the repeal.
• Schedule 1 amendments noted at the end of the Schedule. The Schedule records "sch 1: Am 2020 (702), cl 3; 2022 (709), sec 3." That indicates the blood donor certificate Schedule was amended in 2020 (instrument number or session 702, clause 3) and again in 2022 (instrument 709, section 3). The Regulation text does not provide the contents of those amending instruments, but it records that the Schedule has been changed twice since 2020.
• Commencement (clause 2). The Regulation commences on the day it is published on the NSW legislation website. The commencement note links the replacement to timing mechanics under the Subordinate Legislation Act 1989.

The amendment history in the instrument thus shows: initial enactment (the Regulation as replacement of 2015 instrument), express repeal of the earlier subordinate instrument, a savings clause to maintain continuity, and two schedule amendments recorded in the Schedule’s marginal note. The text does not provide a long legislative history, nor does it include dates of royal assent or of initial making beyond the commencement clause’s operational rule; the Schedule marginal note is the only explicit signposting of subsequent textual amendments.

For practical purposes, the Schedule’s recorded amendments mean that the blood donor certificate has been updated at least twice since the Regulation’s 2020 making. The savings clause means operational continuity from the 2015 Regulation. The Regulation’s cross‑references to other Acts (Human Tissue Act 1983, Interpretation Act 1987, Health Practitioner Regulation National Law (NSW)) remain in place and will govern interpretation of the Regulation unless subsequently amended.

The Regulation as provided contains no case law or litigation record. The text does not report judicial interpretations, appeals, or administrative review decisions. The instrument itself provides no examples of contested provisions or court‑decided points. Consequently:

• There are no cases named or cited in the Regulation text. The document does not record any litigation concerning its provisions.
• Because this Regulation supplies procedural details for the Human Tissue Act 1983, legal challenges that could arise in practice are foreseeable from the content. The Regulation itself, however, does not present any adjudicated examples.

Potential litigation touchpoints that the Regulation’s text suggests (but does not resolve) include uncertainties and implementation risks that commonly produce disputes. These are areas where practitioners or families might seek judicial relief or administrative review, based on the text alone:

• Validity and sufficiency of recorded verbal consent under clause 8(1). The Regulation allows verbal consent from a senior available next of kin provided an audio or audiovisual recording is made and the next of kin has consented to the making of that recording. Disputes may arise about whether a particular recording meets the clause’s requirements, whether the recorded consent was voluntary and informed, or whether the person who gave the recording counted as the appropriate "senior available next of kin". The Regulation does not define "senior available next of kin" or set evidentiary rules for recordings.
• Adequacy of retention and chain of custody for records and tissue. Clause 6(3) imposes a 10‑year retention obligation for certificates; clause 8(2) permits retention of tissue for up to 72 hours in emergency treatments. Litigation could focus on whether retention periods were complied with, whether a certificate was properly witnessed under clause 6(2), or whether tissue retained beyond 72 hours lacked legal basis.
• Application of the 1 litre presumption (clause 7). Clause 7 prescribes 1 litre as the threshold quantity to trigger the Act’s presumption that a person is carrying on a blood supply business. Disputes might emerge over whether particular handling of blood or blood products falls within that presumption, how extractable quantities are measured, and whether the presumption can be rebutted in specific circumstances.

Because the Regulation itself does not provide adjudicated examples, any litigation history must be compiled from court records, administrative tribunal decisions or published judicial opinions outside this Regulation text. The Regulation provides the legal hooks and procedural requirements that may give rise to disputes, but the instrument contains no litigation record or constructed precedent.

The Regulation contains a number of specific mechanics and narrow drafting choices that create potential operational pitfalls for practitioners, employers, donors and administrators. Below are concrete "gotchas" derived from the text that implementers should note.

Certificate retention and penalty

• Short and specific retention duty with a modest penalty. Clause 6(3) requires retention of certificates for not less than 10 years by the person who removed blood or by the employing person or body. The maximum penalty for contravention is 2 penalty units. The "gotcha" is that the obligation is strict and time‑bound: failure to retain the certificate triggers criminal exposure (albeit capped at 2 penalty units). Employers that rely on individual staff to keep loose files may therefore be exposed when staff leave or records are not centralised.

Witness categories and Secretary approval

• Witnesses must be employed where the blood is to be removed and can include employer‑nominated persons only after written approval by the Secretary (clause 6(2)). The "gotcha" is administrative: workplaces that want non‑clinical staff to act as witnesses must obtain written Secretary approval in advance. There is no transitional grace or internal delegation provided by the Regulation, and it places a documentation requirement on employers.

Donor form content and the declaration

• The Schedule contains many personal health and sexual‑behaviour questions (e.g. male‑to‑male sex in the last 3 months, sex work, new partners who live or have lived overseas). The form requires signature "ONLY in the presence of the interviewer" and contains a declaration explicitly warning of penalties for false or misleading information (sch 1). The "gotcha" here is twofold: practitioners must ensure the interviewer presence requirement is met to validate the signature, and donors must be informed that false answers may attract penalties; the Regulation embeds the warning but does not quantify the penalties or specify the prosecutorial basis.

Quantitative presumption at 1 litre

• Clause 7 prescribes that the "prescribed quantity of blood is 1 litre" for the purposes of section 21A(b) of the Act, and equates blood products to the amount derivable from 1 litre. The "gotcha" is that small operators should check whether their typical volumes amount to or exceed 1 litre when aggregated, as the presumption could trigger regulatory obligations applicable to those "carrying on a blood supply business". The Regulation provides no guidance on aggregation, measurement or rebuttal of the presumption.

Verbal consent recording mechanics

• Clause 8(1) allows verbal consent by senior available next of kin only if an audio or audiovisual recording is made and the next of kin has consented to the making of the recording. The "gotcha" is evidential: consent will only be valid under the Regulation if both elements are satisfied. The Regulation does not specify retention periods for consent recordings, procedures for authenticity, transcription standards or privacy safeguards. Practitioners must therefore adopt protocols for making, storing and producing such recordings consistent with other legal obligations (privacy, evidentiary chain) though those obligations are not set out in the Regulation.

72‑hour retention in emergencies

• Clause 8(2) permits tissue removed during urgent treatment to be retained for up to 72 hours where the removal was necessary to save life or prevent serious damage to health. The "gotcha" is definitional: the Regulation’s permitted retention is tight (72 hours) and hinged to a clinical necessity standard ("necessary to save the life of the person or to prevent serious damage to the health"). Services that keep tissue for diagnostic or ancillary reasons must ensure they have legal basis beyond this clause if they intend to retain tissue longer.

Dependence on external registration definitions

• Clause 5 ties the notion of specialist registration to the Health Practitioner Regulation National Law (NSW). The practical "gotcha" is that whether an individual qualifies as a "designated specialist" under the Act depends on a separate legal instrument. That means local lists of specialists or employer titles are not determinative; specialist registration under the National Law is the operative test.

Limited scope of the Regulation’s penalties

• The Regulation sets only one specific penalty quantum (2 penalty units for failure to retain certificates) and otherwise refers donors to unspecified penalties for false information. The "gotcha" is that implementers who expect a detailed schedule of statutory penalties (for various breaches) will not find one here; they must consult the parent Act and other NSW legal instruments for the full enforcement landscape.

Amendment trail for the Schedule

• The marginal note indicates Schedule 1 was amended in 2020 and 2022. The "gotcha" is that forms or templates in use should be checked against the current published version to ensure they reflect the 2020/2022 amendments. The Regulation does not reproduce the amendment instruments in full.

In practice, these textual specifics mean implementers should create concrete operational checklists that address witness approval procedures, certificate retention systems, handling of verbal consent recordings, measurement of blood volumes against the 1 litre threshold, and up‑to‑date form usage.

Compliance under this Regulation is straightforward in concept but requires specific administrative actions. The Regulation converts several procedural requirements into checkable rules. The following practical compliance checklist follows directly from the Regulation’s text.

1. Use the prescribed blood donor certificate form (Schedule 1)

   • Ensure every donor is presented with the exact Schedule 1 form when the Act requires a certificate (clause 6(1); sch 1).
   • The interviewer must be present when the donor signs the certificate; the form instructs donors to "ONLY sign in the presence of the interviewer" (sch 1). Implementers should ensure interviewers are trained to confirm this requirement and to record the presence of the interviewer in logs.

2. Maintain witnesses consistent with clause 6(2)

   • When blood is removed at the place of employment, ensure that the witness is one of: a medical practitioner, a nurse, a donor services nursing assistant employed by the Australian Red Cross Society, or an employer‑nominated person approved in writing by the Secretary (clause 6(2)(a)-(d)).
   • If the employer wishes to nominate non‑clinical staff as witnesses, prepare and submit nominations to the Secretary and obtain written approval before allowing such persons to witness signatures. Maintain copies of the Secretary’s written approvals in the compliance file.

3. Retain certificates for at least 10 years

   • Store each signed certificate in a secure, retrievable records management system for not less than 10 years from the date of signature (clause 6(3)).
   • Identify responsibility: either the person who removed the blood or, if the person acted as an employee or agent, the employing person or body must retain the certificate. Where responsibility is vested in an employer, implement centralised storage and transfer protocols for certificates when staff leave.
   • Be aware that failure to retain as required is an offence with a maximum penalty of 2 penalty units (clause 6(3)). Record retention policies should therefore be auditable.

4. Implement donor interview protocols and warnings

   • Train interviewers to administer the Schedule 1 questions clearly and to ensure truthful completion. The form includes a declaration that the donor understands penalties for false or misleading information (sch 1). Keep signed copies on file.
   • Maintain privacy safeguards for completed forms and ensure secure storage consistent with applicable privacy obligations (the Regulation signals privacy stakes through the content of the form but does not set privacy rules).

5. Monitor volumes against the 1 litre presumption

   • For entities that handle blood or blood products, establish measurement and aggregation procedures to determine whether the quantity handled meets or exceeds the statutory 1 litre presumption (clause 7).
   • If volumes approach the 1 litre threshold in aggregate or per period, consult the Act and regulatory advisers to determine the implications of the "carrying on a blood supply business" presumption and to prepare documentation demonstrating whether the presumption is or is not applicable in particular cases.

6. Procedures for verbal consent to removal of tissue after death

   • Where relying on verbal consent from the senior available next of kin, ensure an audio or audiovisual recording is made and that the next of kin has consented to the recording before the consent is recorded (clause 8(1)).
   • Implement standardised processes to create, secure, and, if necessary, disclose recordings that constitute the recorded consent. The Regulation does not specify retention periods for consent recordings; maintain them in accordance with the records retention policy that covers medical and consent records and any relevant privacy law obligations.

7. Emergency tissue retention compliance

   • Where tissue is removed during urgent medical, dental or surgical treatment to save life or prevent serious damage to health, documentation must be kept showing (a) the clinical necessity for removal and (b) that retention did not exceed 72 hours permitted under clause 8(2). If longer retention is contemplated, ensure a separate lawful basis exists under the Act.
   • Incorporate prompts in clinical documentation systems to mark tissue removed in emergency contexts so retaining staff can apply the 72‑hour rule and release or arrange lawful storage or disposal thereafter.

8. Specialist status mapping

   • For matters requiring a designated specialist under the Act, verify that the clinician holds specialist registration in one of the prescribed specialties under the Health Practitioner Regulation National Law (NSW) (clause 5(1)-(2)). Do not assume that employer job titles suffice; obtain documented evidence of specialist registration under the National Law.

9. Secretary approvals and administrative recordkeeping

   • Keep a register of any employer nominations and the Secretary’s written approvals. Where approvals are in place, ensure the nominated persons are trained and authorised to witness signatures in accordance with clause 6(2)(d).
   • Record decisions, approvals, and revocations carefully, and build processes to present these records in audits or enforcement actions.

10. Stay current with Schedule amendments

• The Schedule notes amendments (2020, 2022). Ensure the organisation uses the current published Schedule 1 form and maintains an audit trail showing the version in use for each certificate.

By translating the Regulation’s prescriptions into operational steps and documentation protocols, regulated entities can meet the Regulation’s explicit duties (use of the specified certificate, witness categories, 10‑year retention, consent recording and emergency retention). Where the Regulation refers to definitions or consequences under the Human Tissue Act or the Health Practitioner Regulation National Law, compliance requires coordination with those instruments and their administrative systems.